Tafolecimab (Anti-PCSK9)
Tafolecimab (Anti-PCSK9) is a human lgG2 monoclonal antibody that specifically targets PCSK-9. It may be used in studies of hypercholesterolaemia. MW :145.34 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3067 |
| Sku # | A3067-1mg*25 |
| Pricing | 1mg*25, $5070.00 |